Phase 1 study of peptide receptor radionuclide therapy (PRRT) with [Y-90-DOTA,Tyr(3)]octreotide in patients with somatostatin receptor positive tumors

Valkema, R;Jamar, François;Pauwels, Stanislas;Kvols, L;Krenning, E.;et.al.
(2003) 16th IRIST Meeting — Location: CAPRI (Italy) (2003)

Files

No attached file found for this publication.

Details

Authors
  • Valkema, R
    Author
  • Author
  • Pauwels, StanislasUCLouvain
    Author
  • Kvols, L
    Author
  • Barone, RaffaellaUCLouvain
    Author
  • Krenning, E.
    Author
Show more
Affiliations

Citations

Valkema, R., Jamar, F., Pauwels, S., Kvols, L., Barone, R., Bakker, W., Lasher, J., & Krenning, E. (2003). Phase 1 study of peptide receptor radionuclide therapy (PRRT) with [Y-90-DOTA,Tyr(3)]octreotide in patients with somatostatin receptor positive tumors. Cancer Biotherapy & Radiopharmaceuticals, 18(2), 295. https://hdl.handle.net/2078.5/141533 (Original work published 2003)